Related references
Note: Only part of the references are listed.APOBEC3 proteins mediate the clearance of foreign DNA from human cells
Mark D. Stenglein et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction
Eric W. Refsland et al.
NUCLEIC ACIDS RESEARCH (2010)
Double-Stranded RNA Analog Poly(I:C) Inhibits Human Immunodeficiency Virus Amplification in Dendritic Cells via Type I Interferon-Mediated Activation of APOBEC3G
Susanna Trapp et al.
JOURNAL OF VIROLOGY (2009)
Defining APOBEC3 Expression Patterns in Human Tissues and Hematopoietic Cell Subsets
Fransje A. Koning et al.
JOURNAL OF VIROLOGY (2009)
A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations
A. Takai et al.
ONCOGENE (2009)
Powerful mutators lurking in the genome
Vincent Petit et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2009)
APOBEC proteins and intrinsic resistance to HIV-1 infection
Michael H. Malim
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2009)
Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma
Francoise Thierry
VIROLOGY (2009)
Deaminase-Independent Inhibition of Parvoviruses by the APOBEC3A Cytidine Deaminase
Inigo Narvaiza et al.
PLOS PATHOGENS (2009)
Conserved and non-conserved features of HIV-1 and SIVagm Vif mediated suppression of APOBEC3 cytidine deaminases
Wenyan Zhang et al.
CELLULAR MICROBIOLOGY (2008)
APOBEC3-independent interferon-induced viral clearance in hepatitis B virus transgenic mice
Priscilla Turelli et al.
JOURNAL OF VIROLOGY (2008)
Human immunodeficiency virus (HIV) type 1 proviral hypermutation correlates with CD4 count in HIV-infected women from Kenya
Allison M. Land et al.
JOURNAL OF VIROLOGY (2008)
Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions
Jean-Pierre Vartanian et al.
SCIENCE (2008)
Variable contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cells
Gustavo H. Kijak et al.
VIROLOGY (2008)
APOBEC3G restricts early HIV-1 replication in the cytoplasm of target cells
Jenny L. Anderson et al.
VIROLOGY (2008)
APOBEC3G Inhibits Elongation of HIV-1 Reverse Transcripts
Kate N. Bishop et al.
PLOS PATHOGENS (2008)
The AID/APOBEC family of nucleic acid mutators
Silvestro G. Conticello
GENOME BIOLOGY (2008)
Vpr.A3A chimera inhibits HIV replication
Renato S. Aguiar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Inhibition of Alpharetrovirus replication by a range of human APOBEC3 proteins
Heather L. Wiegand et al.
JOURNAL OF VIROLOGY (2007)
Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G
Yasumasa Iwatani et al.
NUCLEIC ACIDS RESEARCH (2007)
The interaction of APOBEC3G with human immunodeficiency virus type 1 nucleocapsid inhibits tRNA3Lys annealing to viral RNA
Fei Guo et al.
JOURNAL OF VIROLOGY (2007)
T cells contain an RNase-insensitive inhibitor of APOBEC3G deaminase activity
Beth K. Thielen et al.
PLOS PATHOGENS (2007)
Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity
Ritu Goila-Gaur et al.
RETROVIROLOGY (2007)
Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression
Gang Peng et al.
BLOOD (2007)
Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration
Jean L. Mbisa et al.
JOURNAL OF VIROLOGY (2007)
Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation
Kun Luo et al.
JOURNAL OF VIROLOGY (2007)
Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G
David H. Nguyen et al.
JOURNAL OF VIROLOGY (2007)
All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition
Masanobu Kinomoto et al.
NUCLEIC ACIDS RESEARCH (2007)
Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice
Ai Kotani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family
Ying Dang et al.
JOURNAL OF VIROLOGY (2006)
STAT1-independent cell type-specific regulation of antiviral APOBEC3G by IFN-α
Phuong Thi Nguyen Sarkis et al.
JOURNAL OF IMMUNOLOGY (2006)
Clinical aspects of parvovirus B19 infection
K. Broliden et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Population level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation
Craig Pace et al.
JOURNAL OF VIROLOGY (2006)
APOBEC3 proteins inhibit human LINE-1 retrotransposition
Heide Muckenfuss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Cellular inhibitors of long interspersed element 1 and Alu retrotransposition
Hal P. Bogerd et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Gene array expression profiling in acne lesions reveals marked upregulation of genes involved in inflammation and matrix remodeling
Nishit R. Trivedi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H
M OhAinle et al.
JOURNAL OF VIROLOGY (2006)
APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons
H Chen et al.
CURRENT BIOLOGY (2006)
Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity
G Peng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
The interferon response circuit: Induction and suppression by pathogenic viruses
O Haller et al.
VIROLOGY (2006)
APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells
HP Bogerd et al.
NUCLEIC ACIDS RESEARCH (2006)
Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication
Marianne Bonvin et al.
HEPATOLOGY (2006)
Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif
BP Doehle et al.
VIROLOGY (2005)
Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase
BD Liu et al.
JOURNAL OF VIROLOGY (2005)
APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast
AJ Schumacher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo
R Suspène et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
被撤回的出版物: Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells (Retracted Article. See vol 466, pg 276, 2010)
YL Chiu et al.
NATURE (2005)
G→A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo
TL Kieffer et al.
JOURNAL OF VIROLOGY (2005)
Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity
ENC Newman et al.
CURRENT BIOLOGY (2005)
Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities
MA Langlois et al.
NUCLEIC ACIDS RESEARCH (2005)
Functional analysis of vif protein shows less restriction of human immunodeficiency virus type 2 by APOBEC3G
AC Ribeiro et al.
JOURNAL OF VIROLOGY (2005)
Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes:: Correlation with mutation spectra in vivo
RCL Beale et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway
A Mehle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cytidine deamination of retroviral DNA by diverse APOBEC proteins
KN Bishop et al.
CURRENT BIOLOGY (2004)
APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo
MT Liddament et al.
CURRENT BIOLOGY (2004)
APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication
Q Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins
HL Wiegand et al.
EMBO JOURNAL (2004)
Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication
YH Zheng et al.
JOURNAL OF VIROLOGY (2004)
Retroviral restriction by APOBEC proteins
RS Harris et al.
NATURE REVIEWS IMMUNOLOGY (2004)
The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G
SG Conticello et al.
CURRENT BIOLOGY (2003)
Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex
XH Yu et al.
SCIENCE (2003)
HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability
K Stopak et al.
MOLECULAR CELL (2003)
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
B Mangeat et al.
NATURE (2003)
DNA determination mediates innate immunity to retroviral infection
RS Harris et al.
CELL (2003)
Hypermutation of HIV-1 DNA in the absence of the Vif protein
D Lecossier et al.
SCIENCE (2003)
Constitutive expression of AID leads to tumorigenesis
I Okazaki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
AM Sheehy et al.
NATURE MEDICINE (2003)
HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation
M Marin et al.
NATURE MEDICINE (2003)
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
AM Sheehy et al.
NATURE (2002)
Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4+ T cells
M Janini et al.
JOURNAL OF VIROLOGY (2001)